Summit Therapeutics Inc. (SMMT)

Nasdaq · Healthcare · Biotechnology
$9.95-5.87%As of 2026-11-22 · USD
Last session low $9.89Last session high $10.61
52-week low $9.8952-week high $29.23
Market cap
$7.96B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)30.8In the neutral range (30 to 70)
MACD (12, 26, 9)-1.36Below its signal line (-0.70); histogram -0.65
Bollinger %B (20, 2)2%Inside the bands (9.72 to 19.31)
SMA 2014.52Price is 31.5% below
SMA 5015.75Price is 36.8% below
SMA 20016.06Price is 38.0% below
ATR (20)12.06% of priceAverage true range per day
52-week position0%At the bottom of the 9.89 to 29.23 range

About Summit Therapeutics Inc.

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Latest fiscal yearEnded 2022-12-31: revenue of $705,000 and an operating margin of -9024.3%.

More in Biotechnology